Emiliano J. Calvo
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 283 publications
Phase 1/1b open-label, first-in-human study of HER2×CD3×CD28 trispecific T-cell engager (SAR443216) in participants with R/R HER2-expressing solid tumors.
Journal: Journal for immunotherapy of cancer
Published: August 03, 2026
First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 20, 2026
Human Absorption, Metabolism, and Excretion (hAME) Mass Balance Studies in Patients With Cancer.
Journal: Clinical and translational science
Published: April 10, 2026
Vobramitamab duocarmazine, an anti-B7-H3 antibody-drug conjugate, in patients with advanced solid tumors: Final results of a phase 1 cohort expansion.
Journal: Cancer
Published: April 08, 2026
Sieving for gold: external comparator studies to prioritize drugs for late-stage clinical trial.
Journal: Journal of comparative effectiveness research
Published: February 04, 2026
Tumor-type specific methylation patterns of MTAP in human samples and cell lines.
Journal: Clinical epigenetics
Published: January 17, 2026
Datopotamab Deruxtecan Plus Pembrolizumab With or Without Platinum-Based Chemotherapy for Advanced or Metastatic NSCLC: The Phase Ib TROPION-Lung02 Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 26, 2025
Safety and Efficacy of HexaBody-DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity.
Journal: Clinical and translational science
Published: November 24, 2025
A First-in-Human Phase I Clinical Trial Evaluating Clinical Activity and Proof of Mechanism of Tobemstomig, a PD-1-LAG-3 Bispecific Antibody, in Patients with CPI-Experienced Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 21, 2025
ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 10, 2025
ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 10, 2025
Last Updated: 09/26/2026